Charles Schwab Investment Management Inc Blueprint Medicines Corp Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 604,397 shares of BPMC stock, worth $52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
604,397
Previous 597,232 1.2%
Holding current value
$52 Million
Previous $55.2 Million 4.54%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$82.48 - $101.39 $590,969 - $726,459
7,165 Added 1.2%
604,397 $52.7 Million
Q3 2024

Nov 12, 2024
BUY
$84.1 - $120.5 $4.27 Million - $6.11 Million
50,736 Added 9.28%
597,232 $55.2 Million
Q2 2024

Aug 12, 2024
BUY
$85.18 - $108.78 $3.86 Million - $4.93 Million
45,361 Added 9.05%
546,496 $58.9 Million
Q1 2024

May 08, 2024
BUY
$73.17 - $99.79 $1.83 Million - $2.5 Million
25,072 Added 5.27%
501,135 $47.5 Million
Q4 2023

Feb 06, 2024
BUY
$43.96 - $92.84 $336,118 - $709,854
7,646 Added 1.63%
476,063 $43.9 Million
Q3 2023

Nov 08, 2023
SELL
$46.9 - $66.0 $659,695 - $928,356
-14,066 Reduced 2.92%
468,417 $23.5 Million
Q2 2023

Aug 09, 2023
BUY
$42.2 - $66.37 $404,824 - $636,687
9,593 Added 2.03%
482,483 $30.5 Million
Q1 2023

May 11, 2023
BUY
$37.97 - $50.0 $168,245 - $221,550
4,431 Added 0.95%
472,890 $21.3 Million
Q4 2022

Feb 13, 2023
BUY
$41.06 - $66.48 $441,395 - $714,660
10,750 Added 2.35%
468,459 $20.5 Million
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $623,675 - $970,550
12,491 Added 2.81%
457,709 $30.2 Million
Q2 2022

Aug 15, 2022
SELL
$45.23 - $70.15 $119,000 - $184,564
-2,631 Reduced 0.59%
445,218 $22.5 Million
Q1 2022

May 13, 2022
BUY
$54.1 - $110.08 $533,101 - $1.08 Million
9,854 Added 2.25%
447,849 $28.6 Million
Q4 2021

Feb 11, 2022
SELL
$94.25 - $115.99 $2.6 Million - $3.2 Million
-27,614 Reduced 5.93%
437,995 $46.9 Million
Q3 2021

Nov 16, 2021
BUY
$80.98 - $109.47 $292,823 - $395,843
3,616 Added 0.78%
465,609 $47.9 Million
Q2 2021

Aug 16, 2021
BUY
$82.78 - $101.0 $1.18 Million - $1.44 Million
14,238 Added 3.18%
461,993 $40.6 Million
Q1 2021

May 17, 2021
BUY
$90.71 - $108.28 $3.21 Million - $3.83 Million
35,381 Added 8.58%
447,755 $43.5 Million
Q4 2020

Feb 16, 2021
BUY
$92.08 - $124.48 $1.73 Million - $2.34 Million
18,782 Added 4.77%
412,374 $46.2 Million
Q3 2020

Nov 13, 2020
BUY
$66.45 - $92.7 $39,205 - $54,693
590 Added 0.15%
393,592 $36.5 Million
Q2 2020

Aug 14, 2020
BUY
$57.09 - $79.27 $1.58 Million - $2.19 Million
27,647 Added 7.57%
393,002 $30.7 Million
Q1 2020

May 15, 2020
BUY
$48.11 - $82.22 $2.69 Million - $4.59 Million
55,884 Added 18.06%
365,355 $21.4 Million
Q4 2019

Feb 07, 2020
BUY
$66.73 - $82.59 $361,142 - $446,977
5,412 Added 1.78%
309,471 $24.8 Million
Q3 2019

Nov 08, 2019
BUY
$72.9 - $101.41 $1.33 Million - $1.84 Million
18,186 Added 6.36%
304,059 $22.3 Million
Q2 2019

Aug 09, 2019
BUY
$73.54 - $97.8 $2.96 Million - $3.93 Million
40,225 Added 16.38%
285,873 $27 Million
Q1 2019

May 14, 2019
BUY
$48.7 - $86.6 $422,375 - $751,081
8,673 Added 3.66%
245,648 $19.7 Million
Q4 2018

Feb 14, 2019
BUY
$45.57 - $74.26 $53,408 - $87,032
1,172 Added 0.5%
236,975 $12.8 Million
Q3 2018

Nov 13, 2018
BUY
$58.91 - $78.32 $1.62 Million - $2.15 Million
27,508 Added 13.21%
235,803 $18.4 Million
Q2 2018

Aug 08, 2018
BUY
$60.96 - $101.18 $612,160 - $1.02 Million
10,042 Added 5.07%
208,295 $13.2 Million
Q1 2018

May 07, 2018
BUY
$73.28 - $102.95 $727,890 - $1.02 Million
9,933 Added 5.27%
198,253 $18.2 Million
Q4 2017

Jan 17, 2018
BUY
$62.91 - $88.32 $1.23 Million - $1.72 Million
19,485 Added 11.54%
188,320 $14.2 Million
Q3 2017

Nov 13, 2017
BUY
$42.37 - $69.67 $7.15 Million - $11.8 Million
168,835
168,835 $11.8 Million

Others Institutions Holding BPMC

# of Institutions
385
Shares Held
61.5M
Call Options Held
1.6M
Put Options Held
1.41M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.14B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email